Spatial Omics Market

Spatial Omics Market Size (2024 - 2029)

The global spatial Omics market size is valued at USD 284.32 million in 2024 and is anticipated to reach USD 727.46 million by 2029 with a CAGR of 8.9% in the forecast period.

Spatial omics is defined as the set of technologies that includes genomics, proteomics, transcriptomics, and epigenomics, where spatial omics combine with molecular profiling to localize the presence of cells inside the tissue. This results in the technological study regarding tissue organization and cell regulation. Spatial omics are beneficial in evaluating tissue biomarkers and have gained traction as neurological ailments in recent years. Spatial omics technologies depend on non-microscopic methods such as mass spectroscopy to detect analytes, perform staining and dye techniques, and other applications.

MARKET DRIVERS:

The rising prevalence of cancer worldwide is expected to drive the spatial omics market as it helps identify the specific biomarkers in the tumor and guide targeted therapies with minimal side effects. The spatial omics play a crucial role in providing the correct spatial information regarding the biomolecules and the cells in the tissue. This helps medical professionals to develop personalized treatment possibilities. The increasing variety of genetic disorders and the growing government funding for research activities drive the spatial omics market growth—the increasing product launches. Rising technological advancements in biotechnology, which include omics technologies and molecular tools, are propelling the spatial omics market. The advancements benefit researchers by allowing them to analyze spatial data more efficiently and precisely. Spatial omics are highly beneficial in biotechnology tools as they give precise results, from mapping neural circuits in neuroscience to breaking down cell interactions in cancer research.

The rise in the funding for spatial omics research is due to investments by the market players to bring practical outputs through the technologies. The growing adoption of spatial omics in various fields, such as oncology and genetic disorders, is due to more accessibility and applicability by contributing to the growing healthcare infrastructure. The broad applicability of the spatial omics and the adoption rate are expected to increase during the forecast period.

Spatial omics are gaining traction due to their precise diagnostic methods, which are expected to drive the market over the forecast period. This benefits health professionals in developing highly personalized diagnostic tests, which play a prominent role in disease detection, characterization, and monitoring, by facilitating treatment strategy. The precise diagnostic methods by spatial omics are projected to have promising, accurate, and effective healthcare solutions, especially in oncology and immunology.

Spatial omics technologies are in demand due to their ability to identify specific biomarkers for various diseases. This benefits the researchers in studying and exploring the spatial distribution of molecules in the tissue, which uncovers the unique biomarkers used in disease diagnosis and monitoring. All these possibilities will increase the availability of market growth opportunities during the forecast period.

MARKET RESTRAINTS:

The primary factor restraining the market growth is the high cost of spatial omics. When combined with the need for consumables signs, the equipment used in the spatial omics techniques definitely increases the procedure's cost. The initial investment and maintenance of this equipment and investments in the data analysis software and consumables are hampering the market expansion by limiting adoption.

Another factor hindering the market growth is the need for more skilled personnel. These kinds of innovative and new research techniques require highly skilled personnel—the need for more skilled professionals decreases the adoption of spatial omics by small and medium research organizations. The need for standardized protocols and methodologies impedes the adoption rate of spatial omics.

The market expansion has considerable data storage, transfer, and analysis challenges in small research organizations with limited resources. The data handling issues result in delays and a rise in operational costs, which is expected to limit the market growth. As spatial omics need standardized protocols, it raises concerns regarding data validity and accuracy, which limits the adoption of technology in regulation.

COVID-19 Impact on spatial Omics market:

The pandemic had a negative impact in the early stage due to stringent lockdown regulations, which declined the market revenue with production delays due to the laboratories' closure. However, the second half of the pandemic positively impacted the market expansion as the sales are experiencing a gradual increase due to a rise in consumables revenue. The research study for COVID-19 led to the application of spatial transcriptomic and other techniques, which influenced the adoption of spatial omics by enhancing the market share.

REPORT COVERAGE:

This research report on the Global Spatial Omics Market has been segmented and sub-segmented based on Technology, Product, Work Flow, Sample, End-Use, and region.

Spatial Omics Market - By Technology:

• Spatial Transcriptomics
• Spatial Genomics
• Spatial Proteomics

Spatial transcriptomics dominated the global spatial omics market with the largest share in 2023. The growing advancements in sequencing technology are boosting the transcriptomic study of single cells, Various researchers are focusing on designing novel solutions for genomic analysis by maintaining the spatial information of the tissue. The prominent development of various in-situ methods is influencing the exploration of more spatial information in biological research. All these factors enhance spatial transcriptomics market revenue in the spatial omics market.

The spatial genomics segment is projected to grow significantly over the forecast period.

Spatial Omics Market - By Product:

• Instruments
  • By Mode
    • Automated
    • Semi-automated
    • Manual
  • By Type
    • Sequencing Platforms
    • IHC
    • Flow Cytometry
    • Mass Spectroscopy
    • Consumables
    • Software

The consumables segment dominated the global market in 2023 due to high utilization and the launch of novel products. For Instance, in 2021, Bruker launched new consumables for chemical cross-linking of proteins, which had shown highly beneficial results.

The growth of the instruments segment is associated with the development of consumables, where new instrument launches drive the market expansion with both segments.

The software segment is projected to have steady market growth over the forecast period due to the extensive use of single-cell data analysis.

Spatial Omics Market - By Work Flow:

• Sample Preparation
• Instrumental Analysis
• Data Analysis

The Instrumental analysis segment held the most significant global spatial omics market revenue share in 2023. The rising advancements in instruments such as microscopy and mass spectroscopy are driving market value growth. Mass spectroscopy is the most promising tool for quantifying nucleic acid and proteins. Mass spectroscopy shows several advantages, such as high resolution and high speed in protein profiling, which is beneficial in drug development, biomarker discovery, and diagnostics.

The data analysis segment is expected to witness the fastest growth over the forecast period due to the rising integration of advanced solutions for detailed spatial information for omics studies.

Spatial Omics Market - By Sample:

• FFPE
• Fresh Frozen

The Formalin fixation and paraffin embedding (FFPE) segment dominated the global market in 2023 as it is considered the standard sample primarily used to preserve clinical tissue for diagnosis. Various researchers are focusing on developing new innovative methods to increase the application of FFPE in spatial transcriptomic studies.

Spatial Omics Market - By End-Use:

• Academic & Translational research institutes
• Pharmaceutical & Biotechnology Companies

The academic and translational research institutes segment dominated the global spatial omics market with the most significant share of 89% in 2023. The academic and translational institutes help researchers study genomics with spatial omics to analyze human tissue characteristics.

The Pharmaceutical and biotechnology companies are estimated to have a decent growth rate during the forecast period.

Spatial Omics Market - By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

The North American region dominated the global market with the largest share of 46% in 2023 and is expected to maintain the domination during the forecast period. The rising prevalence of cancer and genetic diseases in the US and Canada, with rising demand for personalized medicine and efficient healthcare infrastructure, are all boosting the market growth in the region. The growing morbidity and mortality rate across the region due to increasing autoimmune disorders, cancer, and others, which require the development of novel therapies, is propelling the global market expansion in the region. The presence of market key players and growing investments by the government in R&D activities are enhancing the market players in launching innovations and programs for the application and discovering which contributes to further market growth.

The Asia Pacific region is projected to expand rapidly over the forecast period. Most companies are collaborating to expand in biological activities, which is estimated to make spatial tools prominent in the forecast period.

KEY MARKET PLAYERS:

NanoString Technologies, Inc., Bio-Techne, 10x Genomics, Dovetail Genomics, Ultivue Inc.,, Bruker Inc., Vizgen Corporation, Akoya Biosciences, Inc., Seven Bridge Genomics, Millennium Science Pty Ltd.

Recent Market Developments:

• In June 2023, Owkin Inc. contributed USD 50 million and collaborated with NanoString Technologies Inc., where the research teams from European and American institutions are projected to use spatial omics technology for cancer research.
• In February 2023, Curio Bioscience launched Curio Seeker, the high-resolution, whole transcriptome spatial mapping kit expected to introduce the company's commercial activities to the public.
• In 2023, OMAPiX, a spatial omics service provider, collaborated with Vizgen, Resolve Biosciences, and Ultive Inc., where these use the technologies for delivering standardized, high-quality spatial transcriptomic and proteomic data. These partnerships are aimed at boosting drug development and life science research.
• In 2023, Bio-Techne and Lunaphore, in combination, work together to develop an automated spatial multiomics solution. The partnership aims to develop a method for identifying protein and RNA biomarkers on a single slide.